http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101130030-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8988 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2010-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101130030-B1 |
| titleOfInvention | Parkinson's disease prevention and treatment composition containing the extract as an active ingredient |
| abstract | The present invention relates to a composition for the prevention and treatment of Parkinson's disease containing the cheonma extract as an active ingredient, specifically, the cheonma extract of the present invention is to reduce the amount of spontaneous motility in the animal model of Parkinson's disease induced by MPTP or MA and It can be used in pharmaceutical compositions and dietary supplements, which are useful for the prevention and treatment of Parkinson's disease by inhibiting the reduction of ataxia performance, reducing dopamine, increasing dopamine metabolism and decreasing tyrosine hydroxylase (TH) protein expression. have. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190024850-A |
| priorityDate | 2010-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.